236 related articles for article (PubMed ID: 9279263)
1. Sociometric risk networks and risk for HIV infection.
Friedman SR; Neaigus A; Jose B; Curtis R; Goldstein M; Ildefonso G; Rothenberg RB; Des Jarlais DC
Am J Public Health; 1997 Aug; 87(8):1289-96. PubMed ID: 9279263
[TBL] [Abstract][Full Text] [Related]
2. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation.
Friedman SR; Kottiri BJ; Neaigus A; Curtis R; Vermund SH; Des Jarlais DC
Am J Epidemiol; 2000 Nov; 152(10):913-22. PubMed ID: 11092433
[TBL] [Abstract][Full Text] [Related]
3. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.
Des Jarlais DC; Friedman SR; Perlis T; Chapman TF; Sotheran JL; Paone D; Monterroso E; Neaigus A
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):67-72. PubMed ID: 9928732
[TBL] [Abstract][Full Text] [Related]
4. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].
de la Fuente L; Bravo MJ; Lew C; Barrio G; Soriano V; Royuela L
Med Clin (Barc); 1999 Nov; 113(17):646-51. PubMed ID: 10618778
[TBL] [Abstract][Full Text] [Related]
5. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection.
Neaigus A; Friedman SR; Curtis R; Des Jarlais DC; Furst RT; Jose B; Mota P; Stepherson B; Sufian M; Ward T
Soc Sci Med; 1994 Jan; 38(1):67-78. PubMed ID: 8146717
[TBL] [Abstract][Full Text] [Related]
6. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
7. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
[TBL] [Abstract][Full Text] [Related]
8. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
Lima ES; Bastos FI; Telles PR; Friedman SR
Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
[TBL] [Abstract][Full Text] [Related]
9. Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996.
Friedman SR; Chapman TF; Perlis TE; Rockwell R; Paone D; Sotheran JL; Des Jarlais DC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):83-91. PubMed ID: 10534151
[TBL] [Abstract][Full Text] [Related]
10. Low and stable prevalence of HIV among drug injectors in Glasgow.
Taylor A; Frischer M; Green ST; Goldberg D; McKeganey N; Gruer L
Int J STD AIDS; 1994; 5(2):105-7. PubMed ID: 8031910
[TBL] [Abstract][Full Text] [Related]
11. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.
Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS
Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303
[TBL] [Abstract][Full Text] [Related]
12. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
[TBL] [Abstract][Full Text] [Related]
13. Sexual risk behaviors of Gay, Lesbian, and bisexual youths in New York City: prevalence and correlates.
Rosario M; Meyer-Bahlburg HF; Hunter J; Gwadz M
AIDS Educ Prev; 1999 Dec; 11(6):476-96. PubMed ID: 10693645
[TBL] [Abstract][Full Text] [Related]
14. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow.
Rhodes TJ; Bloor MJ; Donoghoe MC; Haw S; Ettore B; Platt S; Frischer M; Hunter GM; Taylor A; Finlay A
AIDS Care; 1993; 5(4):413-25. PubMed ID: 8110856
[TBL] [Abstract][Full Text] [Related]
15. Drug scene roles and HIV risk.
Friedman SR; Furst RT; Jose B; Curtis R; Neaigus A; Des Jarlais DC; Goldstein MF; Ildefonso G
Addiction; 1998 Sep; 93(9):1403-16. PubMed ID: 9926546
[TBL] [Abstract][Full Text] [Related]
16. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
18. Sexual behaviors and HIV infection in intravenous drug users in New York City.
Banks SE; Brown LS; Ajuluchukwu D
J Addict Dis; 1991; 10(3):15-23. PubMed ID: 1932149
[TBL] [Abstract][Full Text] [Related]
19. The risk of HIV infection for noninjecting sex partners of injecting drug users in Stockholm.
Käll K
AIDS Educ Prev; 1994 Aug; 6(4):351-64. PubMed ID: 7986655
[TBL] [Abstract][Full Text] [Related]
20. Drug-scene roles and HIV risk among Puerto Rican injection drug users in East Harlem, New York and Bayamón, Puerto Rico.
Friedman SR; Kang SY; Deren S; Robles R; Colón HM; Andia J; Oliver-Velez D; Finlinson A
J Psychoactive Drugs; 2002; 34(4):363-9. PubMed ID: 12562104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
